Strategies in cancer vaccines development (Q35143294)

6 August 2017

1 reference

title

Strategies in cancer vaccines development (English)

1 reference

6 August 2017

5

Thomas Kieber-Emmons

1 reference

6 August 2017

Gina Cunto-Amesty

1

1 reference

6 August 2017

Behjatolah Monzavi-Karbassi

series ordinal

2

1 reference

6 August 2017

Ping Luo

series ordinal

3

1 reference

6 August 2017

Fariba Jousheghany

series ordinal

4

1 reference

6 August 2017

publication date

1 May 2003

1 reference

International Journal for Parasitology

6 August 2017

published in

1 reference

6 August 2017

volume

33

1 reference

6 August 2017

issue

5-6

1 reference

6 August 2017

page(s)

597-613

1 reference

Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide mimics of a tumor antigen induce functional cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

MUC1 cross-reactive Galα(l,3)Gal antibodies in humans switch immune responses from cellular to humoral

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Mimics and cross reactions of relevance to tumour immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Molecular mimicry between Helicobacter pylori and the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Anti-idiotype antibody vaccine therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Natural killer T (NKT) cells and their role in antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide binding and presentation by mouse CD1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Nucleic acid aptamers in cancer medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Mimotopes of cytolytic T lymphocytes in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

CD8+ T cell tolerance and cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

HPV protein/peptide vaccines: from animal models to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Universal tumor antigens as targets for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Glycosphingolipid antigens and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

O-glycosylation of the mucin type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Stuck in the MUC on the long and winding road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Molecular characterization of a monoclonal antibody produced in response to a group C meningococcal polysaccharide peptide mimic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Clinical cancer vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

T cell recognition of Tn-glycosylated peptide antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide mimicry of adenocarcinoma-associated carbohydrate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Activation of T cells via tumor antigen specific chimeric receptors: the role of the intracellular signaling domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Helminth C-type lectins and host-parasite interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A molecular basis for functional peptide mimicry of a carbohydrate antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Human papillomavirus antigens and T-cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide-based cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Aspects of cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Altered saccharide sequences in two groups of patients with metastatic prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Monoclonal antibody therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Mimotopes: realization of an unlikely concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Adjuvant immunotherapy for solid tumors: from promise to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Delivery technologies for human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

T cell-independent antigens type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Current concepts in cancer vaccine strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Priming characteristics of peptide mimotopes of carbohydrate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Amino acid sequence of protein alpha-amylase inhibitor from Streptomyces griseosporeus YM-25.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide ligands for a sugar-binding protein isolated from a random peptide library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Spinning molecular immunology into successful immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Alphavirus vectors and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Generation of dendritic cell-based vaccines for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Early detection of pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Cancer immunotherapy: novel strategies and clinical experiences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

A family of concanavalin A-binding peptides from a hexapeptide epitope library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Antigen-processing machinery breakdown and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

NKT cells - conductors of tumor immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

New aspects of natural-killer-cell surveillance and therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Exploiting dendritic cells to improve vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

CD1--a new paradigm for antigen presentation and T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Dendritic cell-based vaccines and therapies for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Cytokine gene transfection for autologous and allogeneic melanoma vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Peptide mimicry of the meningococcal group C capsular polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

GD2 oligosaccharide: target for cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

The potential of DNA vaccination against tumor-associated antigens for antitumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900054-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7519(03)00054-7

1 reference

6 August 2017

1 reference